APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologics Monoclonal Antibodies Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologics Monoclonal Antibodies Drug Industry Growth and Trends Forecast to 2032

Report ID 173970760120 December 2025104 pages

Choose your research edition.

Industry ResearchBiologics Monoclonal Antibodies Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Monoclonal Antibodies Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologics Monoclonal Antibodies Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Monoclonal Antibodies Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics Monoclonal Antibodies Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Biologics Monoclonal Antibodies Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biologics Monoclonal Antibodies Drug market include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer, Biogen and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologics Monoclonal Antibodies Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologics Monoclonal Antibodies Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologics Monoclonal Antibodies Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologics Monoclonal Antibodies Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biologics Monoclonal Antibodies Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologics Monoclonal Antibodies Drug Market by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Biogen

Amgen

AbbVie

Sobi

Innovent Biologics

Biologics Monoclonal Antibodies Drug Segment by Type

Trastuzumab

Rituximab

Infliximab

Adalimumab

Other

Biologics Monoclonal Antibodies Drug Segment by Application

Cancer

Autoimmune Disease

Other

Biologics Monoclonal Antibodies Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Monoclonal Antibodies Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Monoclonal Antibodies Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Monoclonal Antibodies Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biologics Monoclonal Antibodies Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Monoclonal Antibodies Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biologics Monoclonal Antibodies Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2021-2026) Table 4. Global Biologics Monoclonal Antibodies Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2027-2032) Table 6. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2026) Table 9. Global Biologics Monoclonal Antibodies Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biologics Monoclonal Antibodies Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2026) Table 24. Global Biologics Monoclonal Antibodies Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biologics Monoclonal Antibodies Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biologics Monoclonal Antibodies Drug Industry Trends Table 37. Biologics Monoclonal Antibodies Drug Industry Drivers Table 38. Biologics Monoclonal Antibodies Drug Industry Opportunities and Challenges Table 39. Biologics Monoclonal Antibodies Drug Industry Restraints Table 40. Global Biologics Monoclonal Antibodies Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Company (2021-2026) Table 42. Global Biologics Monoclonal Antibodies Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biologics Monoclonal Antibodies Drug Key Company Headquarters & Area Served Table 44. Global Biologics Monoclonal Antibodies Drug Company, Product Type & Application Table 45. Global Biologics Monoclonal Antibodies Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biologics Monoclonal Antibodies Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Biologics Monoclonal Antibodies Drug Product Portfolio Table 52. Sanofi Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Biologics Monoclonal Antibodies Drug Product Portfolio Table 62. Novartis Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck Biologics Monoclonal Antibodies Drug Product Portfolio Table 67. Merck Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Roche Biologics Monoclonal Antibodies Drug Product Portfolio Table 72. Roche Recent Development Table 73. Eli Lilly Company Information Table 74. Eli Lilly Business Overview Table 75. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Eli Lilly Biologics Monoclonal Antibodies Drug Product Portfolio Table 77. Eli Lilly Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer Biologics Monoclonal Antibodies Drug Product Portfolio Table 82. Pfizer Recent Development Table 83. Biogen Company Information Table 84. Biogen Business Overview Table 85. Biogen Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biogen Biologics Monoclonal Antibodies Drug Product Portfolio Table 87. Biogen Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Amgen Biologics Monoclonal Antibodies Drug Product Portfolio Table 92. Amgen Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AbbVie Biologics Monoclonal Antibodies Drug Product Portfolio Table 97. AbbVie Recent Development Table 98. Sobi Company Information Table 99. Sobi Business Overview Table 100. Sobi Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sobi Biologics Monoclonal Antibodies Drug Product Portfolio Table 102. Sobi Recent Development Table 103. Innovent Biologics Company Information Table 104. Innovent Biologics Business Overview Table 105. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Innovent Biologics Biologics Monoclonal Antibodies Drug Product Portfolio Table 107. Innovent Biologics Recent Development Table 108. North America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2026) Table 111. North America Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Biologics Monoclonal Antibodies Drug Market Share Forecast by Country (2027-2032) Table 113. Europe Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2026) Table 116. Europe Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Biologics Monoclonal Antibodies Drug Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2026) Table 121. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Share Forecast by Country (2027-2032) Table 123. Latin America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2026) Table 126. Latin America Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Biologics Monoclonal Antibodies Drug Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2026) Table 131. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biologics Monoclonal Antibodies Drug Product Image Figure 3. Global Biologics Monoclonal Antibodies Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Biologics Monoclonal Antibodies Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2021-2032) Figure 7. North America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Trastuzumab Image Figure 13. Global Trastuzumab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Rituximab Image Figure 15. Global Rituximab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Infliximab Image Figure 17. Global Infliximab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Adalimumab Image Figure 19. Global Adalimumab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Biologics Monoclonal Antibodies Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Biologics Monoclonal Antibodies Drug Market Share by Type 2025 VS 2032 Figure 24. North America Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2032) Figure 25. Europe Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2032) Figure 27. Latin America Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2032) Figure 29. Cancer Image Figure 30. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Autoimmune Disease Image Figure 32. Global Autoimmune Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Biologics Monoclonal Antibodies Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Biologics Monoclonal Antibodies Drug Market Share by Application 2025 VS 2032 Figure 37. North America Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2032) Figure 38. Europe Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2032) Figure 40. Latin America Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Biologics Monoclonal Antibodies Drug Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Biologics Monoclonal Antibodies Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Biologics Monoclonal Antibodies Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 47. Europe Biologics Monoclonal Antibodies Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Biologics Monoclonal Antibodies Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 50. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 53. Latin America Biologics Monoclonal Antibodies Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Biologics Monoclonal Antibodies Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 56. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Trastuzumab
  • Rituximab
  • Infliximab
  • Adalimumab
  • Other
Applications
  • Cancer
  • Autoimmune Disease
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Biogen
  • Amgen
  • AbbVie
  • Sobi
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biologics Monoclonal Antibodies Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biologics Monoclonal Antibodies Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Biologics Monoclonal Antibodies Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biologics Monoclonal Antibodies Drug Market Size (2021-2032)
  8. 1.5.1 North America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2021-2032)
2 Biologics Monoclonal Antibodies Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Trastuzumab
  3. 2.1.2 Rituximab
  4. 2.1.3 Infliximab
  5. 2.1.4 Adalimumab
  6. 2.1.5 Other
  7. 2.2 Global Biologics Monoclonal Antibodies Drug Market Size by Type
  8. 2.2.1 Global Biologics Monoclonal Antibodies Drug Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Biologics Monoclonal Antibodies Drug Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Biologics Monoclonal Antibodies Drug Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Biologics Monoclonal Antibodies Drug Market Size by Regions
  12. 2.3.1 North America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Breakdown by Type (2021-2026)
3 Biologics Monoclonal Antibodies Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer
  3. 3.1.2 Autoimmune Disease
  4. 3.1.3 Other
  5. 3.2 Global Biologics Monoclonal Antibodies Drug Market Size by Application
  6. 3.2.1 Global Biologics Monoclonal Antibodies Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Biologics Monoclonal Antibodies Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Biologics Monoclonal Antibodies Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Biologics Monoclonal Antibodies Drug Market Size by Regions
  10. 3.3.1 North America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biologics Monoclonal Antibodies Drug Industry Trends
  2. 4.2 Biologics Monoclonal Antibodies Drug Industry Drivers
  3. 4.3 Biologics Monoclonal Antibodies Drug Industry Opportunities and Challenges
  4. 4.4 Biologics Monoclonal Antibodies Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biologics Monoclonal Antibodies Drug Revenue (2021-2026)
  2. 5.2 Global Biologics Monoclonal Antibodies Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biologics Monoclonal Antibodies Drug Key Company Headquarters & Area Served
  4. 5.4 Global Biologics Monoclonal Antibodies Drug Company, Product Type & Application
  5. 5.5 Global Biologics Monoclonal Antibodies Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biologics Monoclonal Antibodies Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biologics Monoclonal Antibodies Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biologics Monoclonal Antibodies Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Biologics Monoclonal Antibodies Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Biologics Monoclonal Antibodies Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck Biologics Monoclonal Antibodies Drug Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Roche Biologics Monoclonal Antibodies Drug Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Biologics Monoclonal Antibodies Drug Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Biologics Monoclonal Antibodies Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biogen Biologics Monoclonal Antibodies Drug Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 Amgen
  50. 6.9.1 Amgen Company Information
  51. 6.9.2 Amgen Business Overview
  52. 6.9.3 Amgen Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Amgen Biologics Monoclonal Antibodies Drug Product Portfolio
  54. 6.9.5 Amgen Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Biologics Monoclonal Antibodies Drug Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Sobi
  62. 6.11.1 Sobi Company Information
  63. 6.11.2 Sobi Business Overview
  64. 6.11.3 Sobi Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sobi Biologics Monoclonal Antibodies Drug Product Portfolio
  66. 6.11.5 Sobi Recent Developments
  67. 6.12 Innovent Biologics
  68. 6.12.1 Innovent Biologics Company Information
  69. 6.12.2 Innovent Biologics Business Overview
  70. 6.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Product Portfolio
  72. 6.12.5 Innovent Biologics Recent Developments
7 North America
  1. 7.1 North America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  3. 7.3 North America Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  3. 10.3 South America Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst